Lattulosio EG 66,7% Sciroppo Lassativo 180 ml

Therapeutic indications

Short-term treatment of occasional constipation.

Dosage

The correct dose is the minimum sufficient to produce easy evacuation of soft stools. It is advisable to initially use the minimum doses provided. When necessary, the dose can then be increased, but without ever exceeding the maximum indicated. Take preferably in the evening. Laxatives should be used as infrequently as possible and for no more than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case. Swallow with an adequate amount of water (a large glass). A diet rich in liquids favors the effect of the medicine. Adults: the average daily dosage is 10 - 15 g in two doses. This dosage can be doubled or halved depending on the individual response or clinical picture. Children: from 2.5 to 10 g / day, even in a single administration, depending on the age and severity of the case. Infants: on average 2.5 g per day. Lactulose is absorbed to a very small extent and has no caloric value. However, LACTULOSE EG contains, in addition to lactulose, also galactose, lactose and small amounts of other sugars. This must be taken into account in the treatment of diabetic patients and in patients on low calorie diets.

Overdose

Excessive doses can cause abdominal pain and diarrhea; consequent losses of fluids and electrolytes must be replaced. See also the information in the section “Special warnings and precautions for use” regarding the abuse of laxatives.

Contraindications

Hypersensitivity to the active substance or to any of the excipients. Laxatives are contraindicated in subjects with acute abdominal pain or of unknown origin, nausea or vomiting, intestinal obstruction or stenosis, rectal bleeding of unknown origin, severe dehydration. Contraindicated in subjects with galactosemia. Generally contraindicated during pregnancy and lactation (see p. 4.6). Generally contraindicated in pediatric age (see p. 4.4)

Side effects

Occasionally: isolated cramping pains or abdominal colic, more frequent in cases of severe constipation. Occasionally: flatulence. Bloating and abdominal cramps, usually mild, subside spontaneously after the first days of treatment. If not, a dose reduction is appropriate.

Pregnancy and breastfeeding

There are no adequate and well-controlled studies on the use of the drug in pregnancy or breastfeeding. Therefore, the medicine should only be used in case of need, under the direct supervision of the doctor, after evaluating the expected benefit to the mother in relation to the possible risk to the fetus or infant.

Special warnings

Warnings The abuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In the most severe cases, dehydration or hypokalaemia may develop, which can lead to cardiac or neuromuscular dysfunctions, especially in the case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause addiction (and, therefore, the possible need to gradually increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). Precautions for use In children under 12 years of age, the medicine can only be used after consulting your doctor. The treatment of chronic or recurrent constipation always requires the intervention of the doctor for the diagnosis, the prescription of drugs and the surveillance during the course of therapy. Consult your doctor when the need for the laxative derives from a sudden change in previous bowel habits (frequency and characteristics of bowel movements) lasting more than two weeks or when the use of the laxative fails to produce effects. It is also advisable for elderly people or those in poor health to consult their doctor before using the medicine. Do not use the drug if abdominal pain, nausea and vomiting are present. In patients presenting with disorders caused by excessive intestinal meteorism it is advisable to start treatment with the minimum doses indicated, these doses may be gradually increased in relation to the patient's response.

Expiry and Retention

None

Active principles

100 ml of syrup contain: Active ingredient: Lactulose 66.7 g

Excipients

Sodium benzoate.